# Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma

> **NCT01441661** · — · COMPLETED · sponsor: **Cancer Foundation, China** · enrollment: 400 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01441661
- **Lead sponsor:** Cancer Foundation, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2013-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01441661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01441661, "Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01441661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*